Edition:
United States

Insider Trading: Acorda Therapeutics Inc (ACOR.O)

ACOR.O on Nasdaq

21.40USD
9 Dec 2016
Change (% chg)

$0.20 (+0.94%)
Prev Close
$21.20
Open
$21.25
Day's High
$22.15
Day's Low
$20.98
Volume
368,712
Avg. Vol
601,629
52-wk High
$43.63
52-wk Low
$16.40

COHEN RON

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 245
Total Shares Held: 48,792,290
3 Mo. Net Change: 480,344
# New Positions: 24
# Closed Positions: 37
# Increased Positions: 96
# Reduced Positions: 110
# Net Buyers: -14

Officers & Directors

Name Age Since Current Position

Ron Cohen

60 President,Chief Executive Officer, Director

David Lawrence

59 2016 Chief Business Operations, Principal Accounting Officer

Andrew Blight

64 2004 Chief Scientific Officer

Jane Wasman

60 2012 President - International, General Counsel, Corporate Secretary

Burkhard Blank

60 2016 Chief Medical Officer

Andrew Hindman

44 2014 Chief Business Development Officer

Lauren Sabella

54 2015 Chief Commercial Officer

Barry Greene

52 2007 Independent Director

Peder Jensen

61 2011 Independent Director

John Kelley

62 2008 Independent Director

Sandra Panem

68 1998 Independent Director

Lorin Randall

72 2006 Independent Director

Steven Rauscher

61 2005 Independent Director

Ian Smith

50 2007 Independent Director